118 related articles for article (PubMed ID: 25731591)
1. In Silico Identification of Novel APRIL Peptide Antagonists and Binding Insights by Molecular Modeling and Immunosorbent Assays.
Silva JH; Calmon-Hamaty F; Savino W; Hahne M; Caffarena ER
Protein Pept Lett; 2015; 22(5):432-42. PubMed ID: 25731591
[TBL] [Abstract][Full Text] [Related]
2. Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.
Schuepbach-Mallepell S; Das D; Willen L; Vigolo M; Tardivel A; Lebon L; Kowalczyk-Quintas C; Nys J; Smulski C; Zheng TS; Maskos K; Lammens A; Jiang X; Hess H; Tan SL; Schneider P
J Biol Chem; 2015 Jun; 290(26):16330-42. PubMed ID: 25953898
[TBL] [Abstract][Full Text] [Related]
3. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
[TBL] [Abstract][Full Text] [Related]
4. Multiple novel classes of APRIL-specific receptor-blocking peptides isolated by phage display.
Gordon NC; Lien S; Johnson J; Wallweber HJ; Tran T; Currell B; Mathieu M; Quan C; Starovasnik MA; Hymowitz SG; Kelley RF
J Mol Biol; 2010 Feb; 396(1):166-77. PubMed ID: 19945466
[TBL] [Abstract][Full Text] [Related]
5. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
González-Mendióroz M; Alvarez-Vázquez AB; Rubio-Martinez J
J Mol Graph Model; 2013 Feb; 39():13-22. PubMed ID: 23202984
[TBL] [Abstract][Full Text] [Related]
7. No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.
Nys J; Smulski CR; Tardivel A; Willen L; Kowalczyk C; Donzé O; Huard B; Hess H; Schneider P
PLoS One; 2013; 8(4):e61350. PubMed ID: 23620746
[TBL] [Abstract][Full Text] [Related]
8. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
[TBL] [Abstract][Full Text] [Related]
10. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice.
Uslu K; Coleman AS; Allman WR; Katsenelson N; Bram RJ; Alugupalli KR; Akkoyunlu M
J Immunol; 2014 Apr; 192(8):3582-95. PubMed ID: 24646744
[TBL] [Abstract][Full Text] [Related]
11. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.
Zonca M; Mancheño-Corvo P; DelaRosa O; Mañes S; Büscher D; Lombardo E; Planelles L
Tissue Eng Part A; 2012 Apr; 18(7-8):852-9. PubMed ID: 22059379
[TBL] [Abstract][Full Text] [Related]
12. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of a variant of TACI (CRD2-shortTACIFc) in Pichia pastoris.
Wang R; Zhou S; Peng X; Zhou XW; Xie ZQ; Wang Y; Mo W; Yu M
Protein Pept Lett; 2012 Mar; 19(3):315-25. PubMed ID: 21933134
[TBL] [Abstract][Full Text] [Related]
14. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma.
Lee L; Draper B; Chaplin N; Philip B; Chin M; Galas-Filipowicz D; Onuoha S; Thomas S; Baldan V; Bughda R; Maciocia P; Kokalaki E; Neves MP; Patel D; Rodriguez-Justo M; Francis J; Yong K; Pule M
Blood; 2018 Feb; 131(7):746-758. PubMed ID: 29284597
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
16. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.
Allman WR; Dey R; Liu L; Siddiqui S; Coleman AS; Bhattacharya P; Yano M; Uslu K; Takeda K; Nakhasi HL; Akkoyunlu M
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4094-103. PubMed ID: 26170307
[TBL] [Abstract][Full Text] [Related]
17. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
18. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
Tran NL; Schneider P; Santiago-Raber ML
Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
[TBL] [Abstract][Full Text] [Related]
19. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
20. BAFF, APRIL and their receptors: structure, function and signaling.
Bossen C; Schneider P
Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]